Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Recruiting
Observational Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Male
- Study type
- Observational
- Participants needed
- 2,500 (estimated)
- Sponsor
- Francis Medical Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsor…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
* Participant is willing and able to provide written informed consent.
Exclusion Criteria:
* Contraindications per the Vanquish IFU
* Previously p…
Contacts